COMP <GO>
BHC vs IDYA // ENTERPRISE SCALE & MARKET CAP
Bausch Health Companies Inc. (NYSE) VS. IDEAYA Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: BHC 7
— IDYA 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: BHC
LAST: $8.91 (+28.76%) • MKT CAP: $3.33B
market-cap
$3.33B
LAST: $32.89 (-3.15%) • MKT CAP: $3.17B
market-cap
$3.17B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BHC VS. IDYA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BHC | IDYA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.60% | -13.80% | +21.40 | BHC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 22.00% | -2.31% | +24.31 | BHC | /fcf-yield <GO> |
| Operating Margin | 17.70% | -60.00% | +77.70 | BHC | /operating-margins <GO> |
| Net Profit Margin | 1.50% | -52.00% | +53.50 | BHC | /net-margins <GO> |
| Revenue Growth (YoY) | 6.70% | 180.00% | -173.30 | IDYA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 21.49 | -21.04 | IDYA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 4/9 | +5.00 | BHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 76.7 | 34.6 | +42.14 | BHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.7x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $3.33B | $3.17B | $161.2M | BHC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BHC REV | IDYA REV | BHC GROSS % | IDYA GROSS % | BHC FCF | IDYA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $10.27B | $218.7M | — | — | $1.00B | -$73.5M |
| FY 2024 | $9.63B | $7.0M | — | — | $1.26B | -$251.4M |
| FY 2023 | $8.76B | $23.4M | — | — | $637.9M | -$115.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BHC // BETA 0.97
IDYA // BETA —